These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 26562414)

  • 21. Galectin-3 and post-myocardial infarction cardiac remodeling.
    Meijers WC; van der Velde AR; Pascual-Figal DA; de Boer RA
    Eur J Pharmacol; 2015 Sep; 763(Pt A):115-21. PubMed ID: 26101067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of GPCR signaling in cardiac Epithelial to Mesenchymal Transformation (EMT).
    Nebigil CG; Désaubry L
    Trends Cardiovasc Med; 2019 May; 29(4):200-204. PubMed ID: 30172578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
    Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY
    Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
    Umbarkar P; Singh S; Arkat S; Bodhankar SL; Lohidasan S; Sitasawad SL
    Free Radic Biol Med; 2015 Oct; 87():263-73. PubMed ID: 26122707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healing after myocardial infarction.
    Ertl G; Frantz S
    Cardiovasc Res; 2005 Apr; 66(1):22-32. PubMed ID: 15769445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressive effect of epigallocatechin-3-O-gallate on endoglin molecular regulation in myocardial fibrosis in vitro and in vivo.
    Lin CM; Chang H; Wang BW; Shyu KG
    J Cell Mol Med; 2016 Nov; 20(11):2045-2055. PubMed ID: 27306149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor-6 (TLR6) deficient mice are protected from myocardial fibrosis induced by high fructose feeding through anti-oxidant and inflammatory signaling pathway.
    Zhang Y; Zhang Y
    Biochem Biophys Res Commun; 2016 Apr; 473(2):388-95. PubMed ID: 26940740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
    Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
    Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure.
    Matsumoto T; Wada A; Tsutamoto T; Ohnishi M; Isono T; Kinoshita M
    Circulation; 2003 May; 107(20):2555-8. PubMed ID: 12742989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and mechanical synergy: cross-talk between integrins and growth factor receptors.
    Ross RS
    Cardiovasc Res; 2004 Aug; 63(3):381-90. PubMed ID: 15276463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell transplantation as a therapy for cardiac fibrosis.
    Elnakish MT; Kuppusamy P; Khan M
    J Pathol; 2013 Jan; 229(2):347-54. PubMed ID: 23011894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration.
    Talman V; Ruskoaho H
    Cell Tissue Res; 2016 Sep; 365(3):563-81. PubMed ID: 27324127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysyl oxidase expression in cardiac fibroblasts is regulated by α2β1 integrin interactions with the cellular microenvironment.
    Gao AE; Sullivan KE; Black LD
    Biochem Biophys Res Commun; 2016 Jun; 475(1):70-5. PubMed ID: 27169768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation.
    Nishioka T; Suzuki M; Onishi K; Takakura N; Inada H; Yoshida T; Hiroe M; Imanaka-Yoshida K
    J Cardiovasc Pharmacol; 2007 May; 49(5):261-8. PubMed ID: 17513943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diabetic cardiomyopathy].
    Huang YQ; Wang X; Kong W
    Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):31-6. PubMed ID: 21417012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial fibrosis seen through the lenses of T-cell biology.
    Ramos G; Hofmann U; Frantz S
    J Mol Cell Cardiol; 2016 Mar; 92():41-5. PubMed ID: 26804387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of myocardial fibrosis by MicroRNAs.
    Bauersachs J
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):454-9. PubMed ID: 20625314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of secreted protein acidic and rich in cysteine (SPARC) in cardiac repair and fibrosis: Does expression of SPARC by macrophages influence outcomes?
    Bradshaw AD
    J Mol Cell Cardiol; 2016 Apr; 93():156-61. PubMed ID: 26582465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrins and the myocardium.
    Ross RS; Borg TK
    Circ Res; 2001 Jun; 88(11):1112-9. PubMed ID: 11397776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.
    Chang WT; Cheng JT; Chen ZC
    Cardiovasc Diabetol; 2016 Aug; 15(1):113. PubMed ID: 27519769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.